EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Heart–Kidney Axis in Heart Failure and Chronic Kidney Disease: Mechanisms, Mediators, and Therapeutic Implications

Aodi Fan, Xinwei Chen, Ke Yang, Xuefang Ma, Haohao Gao, Binyan Wang, Guanwei Fan, Lan Li

Biomolecules · 2026

DOI: 10.3390/biom16091241 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biomolecules, 2026. Verfasst von Aodi Fan und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianj…. Hauptthemen laut MEDLINE: Heart Failure, Kidney, Renal Insufficiency, Chronic, Heart. Die Arbeit nennt 178 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tianjin Municipal Education Commission, Youth Talent Lifting Project of China Association of Chinese Medicine, Special Project for Technological Innovation in New Productive Forces of Modern Chinese Medicines.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The heart–kidney axis has emerged as a central framework for understanding the bidirectional interactions that drive cardiorenal syndrome and broader cardiovascular–kidney–metabolic (CKM) disease. However, existing interpretations have often emphasized hemodynamic and neurohormonal mechanisms without fully integrating the growing evidence for endocrine, inflammatory, and metabolic mediators that coordinate injury across organs. This Review was therefore undertaken to provide an updated and clinically relevant synthesis of the physiological basis of heart–kidney communication, the mechanisms underlying its disruption, and the therapeutic implications of these insights. To achieve this aim, we performed a systematic narrative review of the literature using PubMed, Embase, Web of Science, and Scopus for studies, supplemented by manual screening of reference lists. Priority was given to original studies, large cohort analyses, randomized controlled trials, meta-analyses, and authoritative reviews. We integrated evidence spanning physiological regulation, maladaptive signaling pathways, emerging mediators, experimental models, and evolving treatment strategies. The reviewed evidence indicates that heart–kidney crosstalk is driven not only by altered perfusion and venous congestion, but also by sustained activation of the renin–angiotensin–aldosterone system (RAAS) and sympathetic nervous system (SNS), inflammation, oxidative stress, mitochondrial dysfunction, anemia, uremic toxins, and disordered mineral metabolism. Among novel mediators, fibroblast growth factor 23 (FGF23) emerges as a major bone-derived, chronic kidney disease (CKD)-associated endocrine mediator linking renal injury to cardiac hypertrophy, fibrosis, calcium mishandling, and diastolic dysfunction, whereas Klotho appears to exert counter-regulatory protective effects. Heart-derived natriuretic peptides, including atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP), remain important modulators of renal blood flow, natriuresis, and volume homeostasis. We further highlight the translational relevance of newer biomarkers and therapies, including sodium–glucose cotransporter 2 inhibitors (SGLT2is), glucagon-like peptide-1 receptor agonists (GLP-1 receptor agonists), and mineralocorticoid receptor antagonists (MRAs), which may help address cardiac and renal dysfunction in parallel. Overall, this Review supports a revised conceptual model in which the heart–kidney axis is governed by multidirectional hemodynamic, neurohormonal, immune, and endocrine signaling networks. A more integrated understanding of these mechanisms may improve biomarker discovery, refine risk stratification, and promote therapies that target both organs simultaneously.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureKidneyRenal Insufficiency, ChronicHeartHumansAnimalsSignal TransductionFibroblast Growth Factor-23Renin-Angiotensin SystemCardio-Renal Syndrome

Stichwörter der Autor:innen

CKDCVDHFpEFcardiologyheart–kidney axis

Substanzen

Fibroblast Growth Factor-23

Autor:innen und Institutionen

  • State Key Laboratory of Modern Chinese Medicine, Key Laboratory of Pharmacology of Traditional Chinese Medical Formulae, Ministry of Education, Tianjin University of Traditional Chinese Medicine, Tianjin 301617, China.
  • National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, State Key Laboratory of Component-Based Chinese Medicine, First Teaching Hospital of Tianjin University of Traditional Chinese Medicine…

Förderung

  • Tianjin Municipal Education Commission
  • Youth Talent Lifting Project of China Association of Chinese Medicine
  • Special Project for Technological Innovation in New Productive Forces of Modern Chinese Medicines
  • Scientific Research Project of Tianjin Municipal Education Commission

Zitieren

APA

Fan, A., Chen, X., Yang, K., Ma, X., Gao, H., Wang, B., Fan, G., & Li, L. (2026). The Heart–Kidney Axis in Heart Failure and Chronic Kidney Disease: Mechanisms, Mediators, and Therapeutic Implications. Biomolecules. https://doi.org/10.3390/biom16091241

Vancouver

Fan A, Chen X, Yang K, Ma X, Gao H, Wang B, et al. The Heart–Kidney Axis in Heart Failure and Chronic Kidney Disease: Mechanisms, Mediators, and Therapeutic Implications. Biomolecules. 2026. doi:10.3390/biom16091241

BibTeX
@article{Fan2026,
  author = {Fan, Aodi and Chen, Xinwei and Yang, Ke and Ma, Xuefang and Gao, Haohao and Wang, Binyan and Fan, Guanwei and Li, Lan},
  title = {The Heart–Kidney Axis in Heart Failure and Chronic Kidney Disease: Mechanisms, Mediators, and Therapeutic Implications},
  journal = {Biomolecules},
  year = {2026},
  doi = {10.3390/biom16091241}
}
Kostenlos starten →